Contact
searchSearch
HMP Global
Poll

Poll: Osteoporosis and the Gut Microbiome

10/14/2020

Popular Articles

News
Ultraprocessed Food Intake and SLE Incidence Among Women
07/12/2024
Jessica Garlewicz
Sugar- and artificially sweetened-beverages were among the key contributors to heightened risk of developing systemic lupus erythematosus.
Sugar- and artificially sweetened-beverages were among the key contributors to heightened risk of developing systemic lupus erythematosus.
Sugar- and artificially...
07/12/2024
Rheumatology & Arthritis
News
Subcutaneous Ustekinumab Cost Rose 84% Under Medicare Part D, Set to Drop Under Negotiated Price Reduction
08/15/2024
Rebecca Mashaw
Coverage changes omitted self-injected therapies from Part B, but new negotiated price will reduce costs 66-67%.
Coverage changes omitted self-injected therapies from Part B, but new negotiated price will reduce costs 66-67%.
Coverage changes omitted...
08/15/2024
Rheumatology & Arthritis
Sponsored Video
The RheuMuseum Lecture Series: The Pathogenesis of Psoriatic Arthritis
06/04/2024
The RheuMuseum Lecture Series continues with Professor Iain McInnes taking a deeper dive into the pathogenesis of psoriatic arthritis.
The RheuMuseum Lecture Series continues with Professor Iain McInnes taking a deeper dive into the pathogenesis of psoriatic arthritis.
The RheuMuseum Lecture Series...
06/04/2024
Rheumatology & Arthritis
FDA Alert
FDA Approves Bimekizumab for PsA, nr-axSpA and AS
09/23/2024
Rebecca Mashaw
Already approved for plaque psoriasis, bimekizumab is designed to selectively inhibit interleukin 17A (IL-17A) and interleukin 17F (IL-17F).
Already approved for plaque psoriasis, bimekizumab is designed to selectively inhibit interleukin 17A (IL-17A) and interleukin 17F (IL-17F).
Already approved for plaque...
09/23/2024
Rheumatology & Arthritis
News
Predictors of Demyelinating Disease in axSpA
07/11/2024
Jessica Garlewicz
Key predictors of demyelinating disease development included a diagnosis of axial spondyloarthritis, presence of inflammatory bowel disease, and a history of smoking.
Key predictors of demyelinating disease development included a diagnosis of axial spondyloarthritis, presence of inflammatory bowel disease, and a history of smoking.
Key predictors of demyelinating...
07/11/2024
Rheumatology & Arthritis

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1
SPONSORED
Axial Involvement in SpA, Chapter 1
04/26/2022
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses...
04/26/2022
Rheumatology & Arthritis

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use